Program

Home

Program

Wednesday 13 April 2011
16:00h

Opening by the workshop chairs

Session 1  
16:15 - 16:45h

The History and Evolution of the HIV Epidemic in South Florida
Invited speaker: Margaret Fischl MD, University of Miami, USA

16:45 - 17:15h

Combining Cancer Chemotherapy and Antiviral Therapy: Clinical and Pharmacologic Considerations
Invited speaker: John Deeken MD, Georgetown University, USA

17:15 - 17:45h Abstract Presentations
17:45 - 18:00h

Discussion

Thursday 14 April 2011
Session 2  
08:30 - 09:00h

Nanoformulation - Penetration in Macrophages
Invited speaker: Howard Gendelman MD, University of Nebraska, USA 

09:00 - 09:30h

The application of nanotechnology to improve bioavailability of antiretroviral drugs
Andrew Owen PhD, University of Liverpool, UK

09:30 - 10:30h

Abstract Presentations and Discussion

10:30 - 11:00h

Break

Roundtable

 Dose Optimisation & Simplification

11:00 - 11:25h

Where are the opportunities
Invited speaker: Andrew Hill PhD, University of Liverpool, UK

11:25 - 11:50h

A resource limited perspective
Invited speaker: Gary Maartens MD, University of Cape Town, SA

11:50 - 12:15h

Practical, operational and financial implications
Invited speaker: Stephen Becker MD, Bill & Melinda Gates Foundation, USA

12:15 - 13:00h Discussion
13:00 - 14:00h

Lunch

Session 3  
14:00 - 15:30h

Abstract presentations and Discussion

15:30 - 16:30h Break and Posterviewing session I
Session Clinical Case Presentations
16:30 - 18:00h

Moderators:
Natella Rakhmanina MD, PhD
Michael Neely MD, FCP
Gwen Scott MD

Friday 15 April 2011
Symposium Clinical Pharmacology of Hepatitis Virology
08:30 - 09:00h Translating Molecular Virolgy into Novel Therapies for Hepatitis
Invited speaker: Jeffrey Glenn MD, PhD, Stanford University, USA
09:00 - 09:30h Regulatory Issues related to the development of new drugs for viral Hepatitis
Invited speaker: Kim Struble PharmD, FDA, USA
09:30 - 10:00h Clinical Pharmacology's role in the development of new drugs for viral Hepatitis
Invited speaker: Charles Flexner MD, Johns Hopkins University, USA
10:00 - 10:30h Discussion
10:30 - 11:30h

Break and Poster viewing session II

Session 4  
11:30 - 12:00h Pharmacogenetics of Transporters 
Invited speaker: David Haas MD, Vanderbilt University, USA
12:00 - 12:15h Abstract presentation
  Poster presentation Session
12:15 - 13:00h Abstract presentations and Discussion
13:00 - 14:00h

Lunch

Session 5  
14:00 - 15:30h Abstract presentations
15:30 - 15:45h Final Discussion
15:45 - 16:00h Closing remarks
  • Confirmed Speakers
    Becker, Stephen 2009

    Stephen Becker MD

    Practical, Operational and Financial Implications



  • --------------------------

    John Deeken MD

    Combining Cancer Chemotherapy and Antiviral Therapy: Clinical and Pharmacologic Considerations



    ...

  • -------------------------

    Margaret Fischl MD

    The History and Evolution of the HIV Epidemic in South Florida

    ...

  • -------------------------
    Website foto Flexner

    Charles Flexner MD

    Clinical Pharmacology of Hepatitis



  • -------------------------

    Howard Gendelman MD

    Nanoformulation - Penetration in Macrophages




  • -------------------------

    Jeffrey Glenn MD, PhD

    Translating Molecular Virology into Novel Therapies for Hepatitis



    ...

  • -------------------------

    David Haas MD

    Pharmacogenetics of Transporters




  • -------------------------

    Andrew Hill PhD

    Where are the Opportunities




  • -------------------------

    Gary Maartens MD

    A resource limited Perspective




  • -------------------------
    Neely, Michael 2011

    Michael Neely

    Clinical Case Presentation




  • -------------------------

    Andrew Owen PhD

    Nanoformulation - Bioavailability




  • --------------------------
    Rakhmanina, Natella 2011

    Natella Rakhmanina MD, PhD

    Clinical Case Presentation




  • -------------------------
    Scott, Gwen 2011

    Gwendolyn Scott MD

    Clinical Case Presentation




  • -------------------------

    Kimberley Struble PharmD

    Regulatory Issues of Clin Pharm of Hepatitis Therapy


12th_Int_Work_Clinical_Pharmalogy

Final program 2011

Important Dates

Registration Timeline
Early:     1 December - 23 January 2011
Regular: 24 January - 27 February 2011
Late:      28 February - 3 April 2011
On-site:  13-15 April 2011

Abstract Submission
Start: 1 December 2010
Deadline: 28 January 2011